Doxorubicin induces senescence in HCC cell lines and in sorted EpCAM+/CD133+ liver cancer stem cell (LCSC) and EpCAM −/CD133−nonstem cell populations. The gene discussed is EPCAM; the disease is hepatocellular carcinoma.